CN107727621B - Method for detecting miRNA (micro ribonucleic acid) by using enzyme-labeled DNA (deoxyribonucleic acid) logic system - Google Patents
Method for detecting miRNA (micro ribonucleic acid) by using enzyme-labeled DNA (deoxyribonucleic acid) logic system Download PDFInfo
- Publication number
- CN107727621B CN107727621B CN201710910583.5A CN201710910583A CN107727621B CN 107727621 B CN107727621 B CN 107727621B CN 201710910583 A CN201710910583 A CN 201710910583A CN 107727621 B CN107727621 B CN 107727621B
- Authority
- CN
- China
- Prior art keywords
- logic system
- mirna
- enzyme
- protoporphyrin
- fluorescence intensity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 108020004414 DNA Proteins 0.000 title claims abstract description 22
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 11
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 11
- 102000053602 DNA Human genes 0.000 title description 16
- 229920002477 rna polymer Polymers 0.000 title description 2
- 108091070501 miRNA Proteins 0.000 claims abstract description 16
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 claims abstract description 12
- 229950003776 protoporphyrin Drugs 0.000 claims abstract description 12
- 239000000523 sample Substances 0.000 claims abstract description 6
- 238000006073 displacement reaction Methods 0.000 claims abstract description 5
- 238000001917 fluorescence detection Methods 0.000 claims abstract description 4
- 230000003287 optical effect Effects 0.000 claims abstract description 3
- 239000002679 microRNA Substances 0.000 claims abstract 8
- 108091081406 G-quadruplex Proteins 0.000 claims abstract 4
- 239000000243 solution Substances 0.000 claims description 13
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Inorganic materials [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000001103 potassium chloride Substances 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 230000005284 excitation Effects 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 4
- 238000013461 design Methods 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000008223 sterile water Substances 0.000 claims description 3
- 239000007983 Tris buffer Substances 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 230000003321 amplification Effects 0.000 abstract description 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 2
- 230000000295 complement effect Effects 0.000 abstract 2
- 238000012512 characterization method Methods 0.000 abstract 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 8
- 238000011161 development Methods 0.000 description 5
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000011712 cell development Effects 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000024348 heart neoplasm Diseases 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000003234 fluorescent labeling method Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The patent discloses a method for detecting miRNA by an enzyme-labeled DNA logic system, and relates to the field of fluorescence detection of miRNA. By designing complementary probes, the specific recognition of the target is achieved without adding corresponding labels and specific enzymes. The characterization of optical signal amplification is realized by utilizing the fluorescence enhancement characteristic after protoporphyrin and G-quadruplex are combined, and the aim of detecting a target object is fulfilled. The NOT gate output is achieved by disrupting the binding using complementary, spontaneously-occurring strand displacement reaction probes. The method has low detection cost and high sensitivity.
Description
Technical Field
mirnas are widely present in various animals and plants, and participate in a variety of important life activities. By 6 months 2014, Release 21.0, the latest miRNA database of Sanger institute, has included 28645 miRNA precursors of 223 species, 35828 mature mirnas. At present, more than two thousand mirnas have been found in humans, accounting for 1% of the human genome, and exert regulatory effects on the expression of 30% of genes. Its regulation and control range is not limited to normal physiological process in human body (such as cell proliferation, differentiation, development and apoptosis, etc.), and it also has close relationship with heart disease and tumor occurrence and development, etc.
Background
mirnas are widely present in various animals and plants, and participate in a variety of important life activities. By 6 months 2014, Release 21.0, the latest miRNA database of Sanger institute, has included 28645 miRNA precursors of 223 species, 35828 mature mirnas. At present, more than two thousand mirnas have been found in humans, accounting for 1% of the human genome, and exert regulatory effects on the expression of 30% of genes. Its regulation and control range is not limited to normal physiological process in human body (such as cell proliferation, differentiation, development and apoptosis, etc.), and it also has close relationship with heart disease and tumor occurrence and development, etc.
Abnormal expression of miRNA leads to disease generation and physiological abnormality, and in many cancer cells such as breast cancer cells and colorectal cancer cells, the expression level of miRNA changes, possibly serving as a cancer suppressor gene and a protooncogene. In addition, abnormal expression of mirnas has also been detected in many other diseased cells or tissues. Therefore, timely detection of miRNA in tissue or cell samples is helpful for people to further understand the relationship between miRNA and disease development, and a new idea is provided for early diagnosis of diseases.
At present, common methods for detecting mirnas include a Northern Blotting method, a microarray method, a fluorescent labeling method, a quantitative-reverse transcription (PCR) method, a rolling circle amplification method, a gene chip technology, and the like. These methods have many problems after being improved, such as complicated process, expensive instrument, high experiment cost, and poor sensitivity, and thus have some limitations in clinical application. The methods all show inevitable defects, so that a method is needed to be developed, different specimens and even miRNA with low abundance can be sensitively and quantitatively detected, high homologous miRNA can be respectively homologized, the operation is convenient, and expensive equipment or reagents are not needed. This experiment attempted to develop a simpler and more efficient method for establishing a DNA logic system that could be free of enzyme labeling, which did not require a long analysis time and could observe the results by fluorescence signal intensity changes.
Disclosure of Invention
The invention aims to solve the technical problem of constructing a miRNA detection method of an optical signal DNA logic system without enzyme markers by using a DNA strand displacement technology;
a method for detecting miRNA by an enzyme-labeled DNA logic system is characterized by comprising the following steps:
(1) preparation of the principal solution
Tris-EDTA-KCl buffer: dissolving 0.0605 g of tris (hydroxymethyl) aminomethane, 0.0146g of ethylenediamine tetraacetic acid, 5.84 g of sodium chloride and 0.375 g of potassium chloride in sterile water, fixing the volume to a 50 mL volumetric flask, storing at 4 ℃ for later use, and adjusting the pH to 8.0 when in use;
6 mM protoporphyrin solution: dissolving 0.1879 g protoporphyrin in sterile water, diluting to a constant volume in a 50 mL volumetric flask, storing at 4 ℃ in a dark place for later use, and performing the whole process under the dark condition;
10% ammonium persulfate: 0.2 g of ammonium persulfate is taken and added with 2 mL of sterilized water, and the mixture is uniformly mixed and stored at the temperature of 4 ℃ for standby.
(2) Probe design
The corresponding G1, G2 and I chains were designed according to the target.
(3) Construction of DNA logic System
The target miRNA, G1, and G2 used were centrifuged separately in the rnase-free environment. And (3) performing low-temperature operation, adding 15 mu L of TEK buffer solution, 1 mu M G1, G2 and 10 mu L of target miRNA into a centrifuge tube, mixing uniformly, and centrifuging.
(4) Fluorescence detection
And (3) carrying out fluorescence intensity signal test, wherein the excitation wavelength is fixed to be 410 nm, the emission wavelength is 550-750 nm, the width of the excitation slit is 20 nm, and the width of the emission slit is 20 nm.
The above solution was heated to 88 ℃ for reaction for 10 minutes, slowly cooled to room temperature, and 5. mu.L of 6 mM protoporphyrin solution was added thereto and reacted at room temperature for 1 hour to conduct YES gate fluorescence intensity signal test. 10. mu.L of 4. mu. M I strand was added to the tube, and reacted at room temperature for 1 hour to conduct a NOT gate fluorescence intensity signal test.
The invention has the advantages of
(1) Establishing an enzyme-label-free DNA logic system according to the strand displacement reaction and the fluorescence characteristic of protoporphyrin without carrying out the previous labeling step;
(2) the miRNA is detected by using a fluorescence technology, so that the sensitivity is high, the experiment steps are convenient and fast, and the result can be obtained quickly;
(3) the method has the advantages of low detection cost, high sensitivity and good specificity.
Drawings
FIG. 1 is an experimental schematic of the YES gate of the method described herein.
FIG. 2 is an experimental schematic of the NOT gate of the method described herein.
FIG. 3 is a probe design for the methods described herein.
Detailed Description
For a better understanding of the invention, the following further illustrates the invention with reference to examples and drawings, but the invention is not limited to the following embodiments.
Example 1
A method for detecting miRNA by an enzyme-labeled DNA logic system is characterized by comprising the following steps:
(1) preparation of the principal solution
Tris-EDTA-KCl buffer: 0.0605 g of tris (hydroxymethyl) aminomethane, 0.0146g of ethylenediamine tetraacetic acid, 5.84 g of sodium chloride and 0.375 g of potassium chloride are taken, dissolved in sterilized water, and are added into a volumetric flask with a constant volume of 50 mL, and the volumetric flask is stored at the temperature of 4 ℃ for standby application, and the pH value is adjusted to 8.0 when the volumetric flask is used.
6 mM protoporphyrin solution: taking 0.1879 g protoporphyrin, dissolving with sterilized water, diluting to a constant volume in a 50 mL volumetric flask, storing at 4 ℃ in a dark place for later use, and performing the whole process under the dark condition.
10% ammonium persulfate: 0.2 g of ammonium persulfate is taken and added with 2 mL of sterilized water, and the mixture is uniformly mixed and stored at the temperature of 4 ℃ for standby.
(2) Probe design
The corresponding G1, G2 and I chains were designed according to the target.
(3) Construction of DNA logic System
The target miRNA, G1, and G2 used were centrifuged separately in the rnase-free environment. And (3) performing low-temperature operation, adding 15 mu L of TEK buffer solution, 1 mu M G1, G2 and 10 mu L of target miRNA into a centrifuge tube, mixing uniformly, and centrifuging.
(4) Fluorescence detection
And (3) carrying out fluorescence intensity signal test, wherein the excitation wavelength is fixed to be 410 nm, the emission wavelength is 550-750 nm, the width of the excitation slit is 20 nm, and the width of the emission slit is 20 nm.
The above solution was heated to 88 ℃ for reaction for 10 minutes, slowly cooled to room temperature, and 5. mu.L of 6 mM protoporphyrin solution was added thereto and reacted at room temperature for 1 hour to conduct YES gate fluorescence intensity signal test. 10. mu.L of 4. mu. M I strand was added to the tube, and reacted at room temperature for 1 hour to conduct a NOT gate fluorescence intensity signal test.
Example 2
The detection procedure was the same as in example 1, except that: the initial concentrations of the I solutions were 4. mu.M, 2. mu.M, 0.4. mu.M, 0.3. mu.M, 0.2. mu.M, 0.1. mu.M and 0.05. mu.M, respectively.
Sequence listing
<110> university of Jinan
<120> method for detecting miRNA by enzyme-labeled-free DNA logic system
<130>0913
<141>2017-09-20
<160>4
<170>SIPOSequenceListing 1.0
<210>1
<211>13
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>1
tgggtctacc tca 13
<210>2
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>2
acaacctatg ggtagggcgg g 21
<210>3
<211>31
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>3
agactaaact atacaaccat gctcagatga a 31
<210>4
<211>22
<212>RNA
<213> Artificial Sequence (Artificial Sequence)
<400>4
ugagguagua gguuguauag uu 22
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710910583.5A CN107727621B (en) | 2017-09-29 | 2017-09-29 | Method for detecting miRNA (micro ribonucleic acid) by using enzyme-labeled DNA (deoxyribonucleic acid) logic system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710910583.5A CN107727621B (en) | 2017-09-29 | 2017-09-29 | Method for detecting miRNA (micro ribonucleic acid) by using enzyme-labeled DNA (deoxyribonucleic acid) logic system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107727621A CN107727621A (en) | 2018-02-23 |
| CN107727621B true CN107727621B (en) | 2020-04-17 |
Family
ID=61209199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710910583.5A Active CN107727621B (en) | 2017-09-29 | 2017-09-29 | Method for detecting miRNA (micro ribonucleic acid) by using enzyme-labeled DNA (deoxyribonucleic acid) logic system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107727621B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112048547B (en) * | 2019-06-06 | 2022-05-31 | 同济大学 | A kind of spinal muscular atrophy pathogenic gene detection kit and its application |
| CN110592186B (en) * | 2019-09-02 | 2023-06-16 | 天津科技大学 | AND molecular logic gate sensing system AND preparation method AND application thereof |
| CN113866136A (en) * | 2021-06-16 | 2021-12-31 | 江苏科技大学 | Method for detecting antibiotics through solvent-free single-drop magnetic enrichment-dispersion solid phase extraction method |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7745594B2 (en) * | 2005-07-21 | 2010-06-29 | California Institute Of Technology | Nucleic acid-based logic circuits |
| CN104630363A (en) * | 2015-02-05 | 2015-05-20 | 山东大学 | Method for detecting activity of uracil-DNA glycosylase (UDG) based on fluorescence amplification strategy of label-free non-enzyme DNA machines |
| CN105866079B (en) * | 2016-03-31 | 2019-07-05 | 同济大学 | Molecular Logic Gates construction method based on the interaction of tetra- serobila DNA of fluorescent dye NMM, G-, crown ether and metal ion |
| CN106770143B (en) * | 2017-02-28 | 2020-03-13 | 济南大学 | Biosensor for detecting MiRNA and preparation method thereof |
| CN107142309B (en) * | 2017-05-18 | 2019-12-03 | 陕西师范大学 | Method based on water soluble fluorescence polymer rapid sensitive detection MicroRNA |
| CN107142332A (en) * | 2017-07-17 | 2017-09-08 | 济南大学 | A kind of enzyme DNA machines are used for the method that miRNA is detected |
-
2017
- 2017-09-29 CN CN201710910583.5A patent/CN107727621B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107727621A (en) | 2018-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110218770B (en) | Primer for specifically detecting humanized genome DNA and application thereof | |
| Fish et al. | Circulating microRNA as biomarkers of canine mammary carcinoma in dogs | |
| CN109072205A (en) | nucleic acid detection | |
| Zhou et al. | Highly sensitive and facile microRNA detection based on target triggered exponential rolling-circle amplification coupling with CRISPR/Cas12a | |
| CN108642164B (en) | MiRNA capture probe, separation and amplification integrated detection method and detection kit | |
| CN107727621B (en) | Method for detecting miRNA (micro ribonucleic acid) by using enzyme-labeled DNA (deoxyribonucleic acid) logic system | |
| CN106967794B (en) | Kit and method for detecting miRNA (micro ribonucleic acid) by bidirectional signal amplification | |
| CN107267604B (en) | A highly specific microRNA fluorescence detection method based on short-chain nucleic acid probe and double-stranded specific endonuclease | |
| CN114540503B (en) | Tumor inhibition factor kit Let-7a detection kit based on strand displacement and enzyme-assisted circulation signal amplification and application method thereof | |
| CN103642914B (en) | Plasma/serum circulation microRNA marker related to mlignnt melnom and application of marker | |
| CN104328112B (en) | A kind of method of the endogenous circular rna of quantitative detection for non-disease diagnostic purpose | |
| CN109251964B (en) | Circulating microRNAs detection kit, method for specifically detecting circulating microRNAs and application | |
| CN105177132A (en) | RT-PCR method for quantitatively detecting miRNA | |
| Chen et al. | Label-free and self-assembled fluorescent DNA nanopompom for determination of miRNA-21 | |
| Huang et al. | Dual signal amplification for microRNA-21 detection based on duplex-specific nuclease and invertase | |
| CN107354227A (en) | MicroRNA probe one-step method real-time fluorescent quantitative PCR detecting methods | |
| CN110628888B (en) | A set of miRNA-21-triggered assembly of nucleic acid probes and cytofluorescence imaging | |
| Song et al. | Research progress and potential application of microRNA and other non-coding RNAs in forensic medicine | |
| Nie et al. | Enzyme-assisted amplification of target cycle triggers the unlocking of locked hairpin probes for let-7a detection | |
| CN113604541A (en) | Gene chain detection method based on reticular hybridization chain reaction | |
| CN108384832B (en) | Method for detecting miRNA (micro ribonucleic acid) by branch rolling circle amplification combined with photonic crystal | |
| CN109593852B (en) | Serum miRNA marker related to nasopharyngeal carcinoma auxiliary diagnosis and application thereof | |
| RU2569154C1 (en) | Differential diagnostic technique for individual's thyroid new growths | |
| CN115927554B (en) | A method for detecting miRNA using photonic crystal chip and recombinase polymerase amplification | |
| CN114196752B (en) | miR-21 detection kit based on Cas14 and strand displacement amplification and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |